Blog / Archives
Macro Headwinds Stall Biotech Stocks and ASH Momentum Fades…Update-1
Update 12/18 Market Rockets to Records But Biotechs Left Behind Ebullience reigned today stoked by tax cuts around the corner. Although many talking heads have said that the tax cuts are "baked in"...
Rayno BioBeat #7: Biotech Green Screen Day Off Recent Bottom…Update-2
Update 12/12/17 Biotech Rally Stalls at Resistance Celgene (CELG) holds $109. Mid-caps red especially INCY PTLA RDUS. Mixed market on low volume. Alexion (ALXN) trying to bounce. ===============...
West Coast Weather Update: LaNina Hell Comes to California…Update-3/18
2018 LaNina Delivers March Storms-Blocking High Pressure Gone! This NOAA site called the change in February and predicts more cold and wet weather ahead. Mammoth Mountain Expects Big Storms in...
Sluggish Biotech Stocks: Five Underlying Factors Plus A Sector Shift?
MegaCap Tech Stocks Take a Big Hit-Volatility Rising in a Sector Shift Market Rotation Supports Overall Market-S&P 500 Stable today up 17% YTD Sluggish Biotech Now Just a Market Performer With IBB...
Rayno Biopharmaceutical Portfolio Update with Biotech Holding: CELG,RHHBY,XBI…Update 11/29 Rotation Day
11/29/17 Market Reversal in Early Trading 11:35a -FAANG sell-off Stocks show a rotation out of technology and into financials and cyclical consumer goods. XLK is down 2.2%, XLV up 0.66%, IBB up...
Biotech Correction: Just a market rotation or slower growth ahead?
Biotech Correction: Sell-Off Has Reached 10% over Three Months Biotechs under pressure-has revenue growth slowed? Technicals-a break through bottom channel. Need a bounce today. Celgene is a...
LaNina is Here with First Major West Coast Storm of Season in Coming Days
A LaNina Advisory was Issued on November 9 This weak LaNina generally affects climate as follows: "The outlooks generally favor above-average temperatures and below-median precipitation across the...
Biotech Hangover: Recent Earnings Feed Caution with No Near Term Catalysts
Biotech Hangover from Earnings Clouds Outlook Healthcare sector (XLV) lagging technology (QQQ) and FAANG stocks. No earnings catalysts until Jan 2018 but Q4 has seen strong seasonality. Technicals...
Rayno Biopharmaceutical Portfolio Update: Buy and Hold is the Key…Update-2
Update 11/8/17 ...Per comments on Monday. Celgene (CELG) technicals are holding at $102-103 so we will add CELG to the Rayno Portfolio at a price of ~$102.5. The stock was battered on earnings news...
Rayno BioBeat #6: What Have I Missed After Two Weeks of Travel and Away From Trading Biotech Stocks?…Update 11/3
BioBeat Market Update...Technicals Firming Up 11/3/17 11am A lot of green screen today so time to nibble but I would prefer to pick stocks rather than play the ETF game. Recent trades we made are:...